Gilead Wins Appellate Trademark Victory on Importation Claims

On August 13, 2026, the firm announced a significant appellate victory for Gilead Sciences, Inc. in litigation involving claims that defendants violated the company’s trademark rights by facilitating the importation of Gilead-branded medicines.

The decision upholds protections against unauthorized parallel importation that could undermine brand integrity and consumer safety standards associated with pharmaceutical products.

Details of the underlying dispute center on the scope of contributory liability for trademark infringement in the context of cross-border supply chains. The appellate court’s ruling affirms Gilead’s position on the enforcement of its marks against such activities.

The outcome provides further precedent for brand owners in the life sciences sector seeking to control the distribution of their products through trademark enforcement.

Sources: https://www.pbwt.com/news/firm-achieves-appellate-victory-on-behalf-of-gilead-sciences https://www.ipupdate.com/2026/08/keyword-bidding-alone-doesnt-constitute-trademark-infringement/